These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1590376)

  • 1. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
    Ewart HS; Carroll R; Severson DL
    Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N; Lim F; Cam MC; Rodrigues B
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL; Lee M; Carroll R
    Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
    Ramírez I; Severson DL
    Biochem J; 1986 Aug; 238(1):233-8. PubMed ID: 3800935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.